Literature DB >> 28581512

Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40.

Jun Lu1, Noel Byrne2, John Wang3, Gerard Bricogne4, Frank K Brown1, Harry R Chobanian5, Steven L Colletti5, Jerry Di Salvo3, Brande Thomas-Fowlkes3, Yan Guo5, Dawn L Hall2, Jennifer Hadix2, Nicholas B Hastings3, Jeffrey D Hermes2, Thu Ho2, Andrew D Howard6, Hubert Josien5, Maria Kornienko2, Kevin J Lumb2, Michael W Miller5, Sangita B Patel1, Barbara Pio5, Christopher W Plummer5, Bradley S Sherborne1, Payal Sheth3, Sarah Souza3, Srivanya Tummala2, Clemens Vonrhein4, Maria Webb3, Samantha J Allen2, Jennifer M Johnston1, Adam B Weinglass3, Sujata Sharma2, Stephen M Soisson1.   

Abstract

Clinical studies indicate that partial agonists of the G-protein-coupled, free fatty acid receptor 1 GPR40 enhance glucose-dependent insulin secretion and represent a potential mechanism for the treatment of type 2 diabetes mellitus. Full allosteric agonists (AgoPAMs) of GPR40 bind to a site distinct from partial agonists and can provide additional efficacy. We report the 3.2-Å crystal structure of human GPR40 (hGPR40) in complex with both the partial agonist MK-8666 and an AgoPAM, which exposes a novel lipid-facing AgoPAM-binding pocket outside the transmembrane helical bundle. Comparison with an additional 2.2-Å structure of the hGPR40-MK-8666 binary complex reveals an induced-fit conformational coupling between the partial agonist and AgoPAM binding sites, involving rearrangements of the transmembrane helices 4 and 5 (TM4 and TM5) and transition of the intracellular loop 2 (ICL2) into a short helix. These conformational changes likely prime GPR40 to a more active-like state and explain the binding cooperativity between these ligands.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28581512     DOI: 10.1038/nsmb.3417

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  42 in total

1.  Allosteric agonist modulators.

Authors:  Terry Kenakin
Journal:  J Recept Signal Transduct Res       Date:  2007       Impact factor: 2.092

2.  The second intracellular loop of the m5 muscarinic receptor is the switch which enables G-protein coupling.

Authors:  E S Burstein; T A Spalding; M R Brann
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

3.  Role of GPR40 in fatty acid action on the beta cell line INS-1E.

Authors:  Hagit Shapiro; Sigal Shachar; Israel Sekler; Michal Hershfinkel; Michael D Walker
Journal:  Biochem Biophys Res Commun       Date:  2005-09-16       Impact factor: 3.575

Review 4.  Lipid-protein interactions in biological membranes: a structural perspective.

Authors:  A G Lee
Journal:  Biochim Biophys Acta       Date:  2003-05-02

5.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

6.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

7.  Activation and allosteric modulation of a muscarinic acetylcholine receptor.

Authors:  Andrew C Kruse; Aaron M Ring; Aashish Manglik; Jianxin Hu; Kelly Hu; Katrin Eitel; Harald Hübner; Els Pardon; Celine Valant; Patrick M Sexton; Arthur Christopoulos; Christian C Felder; Peter Gmeiner; Jan Steyaert; William I Weis; K Christopher Garcia; Jürgen Wess; Brian K Kobilka
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

8.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

9.  Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor.

Authors:  Daniel C-H Lin; Qi Guo; Jian Luo; Jane Zhang; Kathy Nguyen; Michael Chen; Thanh Tran; Paul J Dransfield; Sean P Brown; Jonathan Houze; Marc Vimolratana; Xian Yun Jiao; Yingcai Wang; Nigel J M Birdsall; Gayathri Swaminath
Journal:  Mol Pharmacol       Date:  2012-08-02       Impact factor: 4.054

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  51 in total

1.  Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.

Authors:  Nathan Robertson; Mathieu Rappas; Andrew S Doré; Jason Brown; Giovanni Bottegoni; Markus Koglin; Julie Cansfield; Ali Jazayeri; Robert M Cooke; Fiona H Marshall
Journal:  Nature       Date:  2018-01-03       Impact factor: 49.962

2.  Does the Lipid Bilayer Orchestrate Access and Binding of Ligands to Transmembrane Orthosteric/Allosteric Sites of G Protein-Coupled Receptors?

Authors:  Christopher T Szlenk; Jeevan B Gc; Senthil Natesan
Journal:  Mol Pharmacol       Date:  2019-04-08       Impact factor: 4.436

Review 3.  Emerging structural biology of lipid G protein-coupled receptors.

Authors:  Martin Audet; Raymond C Stevens
Journal:  Protein Sci       Date:  2019-02       Impact factor: 6.725

4.  A benchmark study of loop modeling methods applied to G protein-coupled receptors.

Authors:  Lee H Wink; Daniel L Baker; Judith A Cole; Abby L Parrill
Journal:  J Comput Aided Mol Des       Date:  2019-05-23       Impact factor: 3.686

Review 5.  Ligand binding at the protein-lipid interface: strategic considerations for drug design.

Authors:  Jian Payandeh; Matthew Volgraf
Journal:  Nat Rev Drug Discov       Date:  2021-07-13       Impact factor: 84.694

6.  Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds.

Authors:  Yong Yao Loh; Kazunori Nagao; Andrew J Hoover; David Hesk; Nelo R Rivera; Steven L Colletti; Ian W Davies; David W C MacMillan
Journal:  Science       Date:  2017-11-09       Impact factor: 47.728

7.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

8.  An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury.

Authors:  Xiao-Jing Zhang; Xu Cheng; Zhen-Zhen Yan; Jing Fang; Xiaozhan Wang; Weijun Wang; Zhen-Yu Liu; Li-Jun Shen; Peng Zhang; Pi-Xiao Wang; Rufang Liao; Yan-Xiao Ji; Jun-Yong Wang; Song Tian; Xue-Yong Zhu; Yan Zhang; Rui-Feng Tian; Lin Wang; Xin-Liang Ma; Zan Huang; Zhi-Gang She; Hongliang Li
Journal:  Nat Med       Date:  2017-12-11       Impact factor: 53.440

9.  Identification and characterization of fragment binding sites for allosteric ligand design using the site identification by ligand competitive saturation hotspots approach (SILCS-Hotspots).

Authors:  Alexander D MacKerell; Sunhwan Jo; Sirish Kaushik Lakkaraju; Christoffer Lind; Wenbo Yu
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-01-03       Impact factor: 3.770

10.  Benchmarking GPCR homology model template selection in combination with de novo loop generation.

Authors:  Gregory L Szwabowski; Paige N Castleman; Chandler K Sears; Lee H Wink; Judith A Cole; Daniel L Baker; Abby L Parrill
Journal:  J Comput Aided Mol Des       Date:  2020-07-31       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.